Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
Vikas Naik, Deepak Agrawal, SS Kale,  MS Sharma, BS Sharma, AK Mahapatra Department of Neurosurgery & Gamma-Knife surgery,...
<ul><li>Posterior third ventricular tumors(PTVT)  </li></ul><ul><li>diverse histology  </li></ul><ul><ul><li>Third ventric...
<ul><li>Benign </li></ul><ul><ul><li>Meningiomas </li></ul></ul><ul><ul><li>Ependymomas </li></ul></ul><ul><ul><li>Teratom...
<ul><li>CSF diversion </li></ul><ul><li>Microneurosurgery </li></ul><ul><li>Radiation therapy </li></ul><ul><li>Chemothera...
<ul><li>Microneurosurgery-  complex anatomy vasculature, critical structures  limit complete resection </li></ul><ul><li>R...
<ul><li>To evaluate the effectiveness of gamma knife (GK) surgery in posterior third ventricular tumors as a primary treat...
<ul><li>Retrospective Study  </li></ul><ul><li>July 97-2009 </li></ul><ul><li>Study conducted at AIIMS </li></ul><ul><li>D...
<ul><li>Inclusion criteria  </li></ul><ul><li>Tumors in and around the posterior third ventricular region who received Gam...
<ul><li>Clinical examination </li></ul><ul><li>Biopsy reviewed </li></ul>12/18/2009 NSI-2009
<ul><li>Primary GK </li></ul><ul><ul><li>GK based on Imaging +/- tumor markers </li></ul></ul><ul><ul><li>Biopsy +GK </li>...
<ul><li>GK was done on Leksell B system </li></ul><ul><li>Parameters assessed </li></ul><ul><ul><li>Tumor volume </li></ul...
<ul><li>Neuroradiologist reviewed any change in size by visual and manual measurement </li></ul><ul><li>Tumor control- sam...
<ul><li>Total -17 patients </li></ul><ul><li>Age range 14-74 years (mean-36.8 years) </li></ul><ul><li>M:F 7:10 </li></ul>...
12/18/2009 NSI-2009
<ul><li>Tumor volume  -  1-16.8 cm3 (mean-6.06cm3) </li></ul><ul><li>Radiation dose -  11-25 Gy  (mean-15.35Gy) </li></ul>...
12/18/2009 NSI-2009 Diagnosis  Histology proven  MRI based  Csf diversion  Adjuvant RT Adjuvant CT Meningiomas  (8) 4 4 1 ...
12/18/2009 NSI-2009
<ul><li>Primary GK </li></ul><ul><li>Beningn  </li></ul><ul><li>-  Meningioma (4) </li></ul><ul><li>- Pinealocytoma (1) </...
<ul><li>Seconadry GK </li></ul><ul><li>Beningn  </li></ul><ul><li>- Meningioma (4) </li></ul><ul><li>-Glioma (2) </li></ul...
12/18/2009 NSI-2009 Symptom No of patients  in Primary GK No of patients  in Secondary GK Percentage HEADACHE 4 4 47 ASYMP...
12/18/2009 NSI-2009 SIGNS No of patients of  Primary GK No of patients of secondary  GK PERCENTAGE NO DEFICITS 5 3 47 HEMI...
<ul><li>PRIMARY GK </li></ul>12/18/2009 NSI-2009 Diagnosis  Follow up period (months) Tumor volume (cm3) Radiation iso dos...
SECONDARY GK 12/18/2009 NSI-2009 Diagnosis  Follow up period (months) Tumor volume (cm3) Radiation iso dose (Gy) Tumor con...
Pinealocytoma at GK Pinealocytoma post 24 months  GK 12/18/2009 NSI-2009
Meningioma at GK Meningioma after 75 months GK 12/18/2009 NSI-2009
Pinealoblastoma Pre- Operative  12/18/2009 NSI-2009
At GK planning Pinealoblastoma 9 month after GK 12/18/2009 NSI-2009
<ul><li>Decrease in size  -  7/14(50%) patients  </li></ul><ul><li>Same size  -  6/14 (42.8%) patients  </li></ul><ul><li>...
<ul><li>Primary GK in beningn disease </li></ul><ul><li>All patients had 100 % tumor control rates at 27 months   </li></u...
<ul><li>Tatsuya Kobayashi et al studied out of 30 patients who were given radiosurgery after conventional treatment and co...
<ul><li>L Manera et al observed effective tumor control in germinomas, pinealoblastomas with recovery o f normal CSF pathw...
<ul><li>GK surgery valuable and safe alternative as a Primary treatment for  posterior third ventricular tumors </li></ul>...
Upcoming SlideShare
Loading in …5
×

Gamma knife in posterior third ventricular tumors

2,503 views

Published on

Published in: Health & Medicine
  • Be the first to comment

Gamma knife in posterior third ventricular tumors

  1. 1. Vikas Naik, Deepak Agrawal, SS Kale, MS Sharma, BS Sharma, AK Mahapatra Department of Neurosurgery & Gamma-Knife surgery, All India Institute of Medical Sciences, New Delhi
  2. 2. <ul><li>Posterior third ventricular tumors(PTVT) </li></ul><ul><li>diverse histology </li></ul><ul><ul><li>Third ventricle, </li></ul></ul><ul><ul><li>Velum interpositum, </li></ul></ul><ul><ul><li>Thalamus, </li></ul></ul><ul><ul><li>Midbrain, </li></ul></ul><ul><ul><li>Tentorium, </li></ul></ul><ul><ul><li>Splenium, </li></ul></ul><ul><ul><li>Quadrigeminal cistern or </li></ul></ul><ul><ul><li>posterior vasculature </li></ul></ul>12/18/2009 NSI-2009
  3. 3. <ul><li>Benign </li></ul><ul><ul><li>Meningiomas </li></ul></ul><ul><ul><li>Ependymomas </li></ul></ul><ul><ul><li>Teratomas </li></ul></ul><ul><ul><li>Pinealocytomas </li></ul></ul><ul><li>Malignant </li></ul><ul><ul><li>Germ cell tumors </li></ul></ul><ul><ul><li>Non-Germ cell tumors </li></ul></ul><ul><ul><li>Metstasis </li></ul></ul>12/18/2009 NSI-2009
  4. 4. <ul><li>CSF diversion </li></ul><ul><li>Microneurosurgery </li></ul><ul><li>Radiation therapy </li></ul><ul><li>Chemotherapy </li></ul><ul><li>Radiosurgery </li></ul>12/18/2009 NSI-2009
  5. 5. <ul><li>Microneurosurgery- complex anatomy vasculature, critical structures limit complete resection </li></ul><ul><li>Radiation therapy- cognitive impairment, radiation toxicity, hormonal imbalances </li></ul><ul><li>Chemotherapy associated toxicity </li></ul>12/18/2009 NSI-2009
  6. 6. <ul><li>To evaluate the effectiveness of gamma knife (GK) surgery in posterior third ventricular tumors as a primary treatment or in conjunction with surgery and/or biopsy </li></ul>12/18/2009 NSI-2009
  7. 7. <ul><li>Retrospective Study </li></ul><ul><li>July 97-2009 </li></ul><ul><li>Study conducted at AIIMS </li></ul><ul><li>Data collected from hospital records, patient files. </li></ul>12/18/2009 NSI-2009
  8. 8. <ul><li>Inclusion criteria </li></ul><ul><li>Tumors in and around the posterior third ventricular region who received Gamma-knife radio-surgery at our institute were included in the study </li></ul>12/18/2009 NSI-2009
  9. 9. <ul><li>Clinical examination </li></ul><ul><li>Biopsy reviewed </li></ul>12/18/2009 NSI-2009
  10. 10. <ul><li>Primary GK </li></ul><ul><ul><li>GK based on Imaging +/- tumor markers </li></ul></ul><ul><ul><li>Biopsy +GK </li></ul></ul><ul><li>Secondary GK </li></ul><ul><ul><li>GK following radical surgery </li></ul></ul>12/18/2009 NSI-2009
  11. 11. <ul><li>GK was done on Leksell B system </li></ul><ul><li>Parameters assessed </li></ul><ul><ul><li>Tumor volume </li></ul></ul><ul><ul><li>Marginal dose </li></ul></ul><ul><li>Follow up at 6 monthly interval </li></ul><ul><ul><li>CEMRI </li></ul></ul><ul><ul><ul><li>MRI screening spine + CSF markers (when required) </li></ul></ul></ul>12/18/2009 NSI-2009
  12. 12. <ul><li>Neuroradiologist reviewed any change in size by visual and manual measurement </li></ul><ul><li>Tumor control- same or decrease in size as compared to at time of GK </li></ul>12/18/2009 NSI-2009
  13. 13. <ul><li>Total -17 patients </li></ul><ul><li>Age range 14-74 years (mean-36.8 years) </li></ul><ul><li>M:F 7:10 </li></ul><ul><li>Follow up 4-75 months (mean-31.23 months) </li></ul><ul><ul><li>1 patient lost to follow up. </li></ul></ul>12/18/2009 NSI-2009
  14. 14. 12/18/2009 NSI-2009
  15. 15. <ul><li>Tumor volume - 1-16.8 cm3 (mean-6.06cm3) </li></ul><ul><li>Radiation dose - 11-25 Gy (mean-15.35Gy) </li></ul><ul><li>Tumor volume coverage - 88%-94% (mean-91%) </li></ul><ul><li>3/17 patients underwent radiation or chemotherapy as adjuvant treatment. </li></ul>12/18/2009 NSI-2009
  16. 16. 12/18/2009 NSI-2009 Diagnosis Histology proven MRI based Csf diversion Adjuvant RT Adjuvant CT Meningiomas (8) 4 4 1 0 0 Pineal tumors (4) 3 1 3 1 1 Gliomas (3) 2 1 1 1 0 PNET (1) 1 0 1 0 1 Metastasis (1) 0 1 0 0 0 Total (17) 10 7 6 2 2
  17. 17. 12/18/2009 NSI-2009
  18. 18. <ul><li>Primary GK </li></ul><ul><li>Beningn </li></ul><ul><li>- Meningioma (4) </li></ul><ul><li>- Pinealocytoma (1) </li></ul><ul><li>- Glioma (1) </li></ul><ul><li>Malignant </li></ul><ul><li>- Pinealoblastoma (2) </li></ul><ul><li>- Metastasis ( 1) </li></ul>12/18/2009 NSI-2009
  19. 19. <ul><li>Seconadry GK </li></ul><ul><li>Beningn </li></ul><ul><li>- Meningioma (4) </li></ul><ul><li>-Glioma (2) </li></ul><ul><li>Malignant </li></ul><ul><li>- Pinealoblastoma (1) </li></ul><ul><li>-PNET (1) </li></ul>12/18/2009 NSI-2009
  20. 20. 12/18/2009 NSI-2009 Symptom No of patients in Primary GK No of patients in Secondary GK Percentage HEADACHE 4 4 47 ASYMPTOMATIC 4 1 29.4 VOMITING 1 2 17.6 HEMIPARESIS 1 2 17.6 DROOPING OF EYELID 1 1 11.76 SEIZURES 1 0 5.8 MEMORY IMPAIRMENT 1 0 5.8 GAIT ATAXIA 1 0 5.8 URINARY INCONTINIENCE 1 0 5.8 DIPLOPIA 1 0 5.8
  21. 21. 12/18/2009 NSI-2009 SIGNS No of patients of Primary GK No of patients of secondary GK PERCENTAGE NO DEFICITS 5 3 47 HEMIPARESIS 1 3 23.5 PAPILLOEDEMA 2 1 17.6 PARINAUDS 1 1 11.76 SEVENTH NERVE 1 1 11.76 THIRD NERVE 1 1 11.76 RECENT MEMORY 1 0 5.8 NYSTAGMUS 0 1 5.8
  22. 22. <ul><li>PRIMARY GK </li></ul>12/18/2009 NSI-2009 Diagnosis Follow up period (months) Tumor volume (cm3) Radiation iso dose (Gy) Tumor control Worsening Beningn Meningiomas 41 9.05 11.8 4/4 - Pinealocytomas 36 2.2 15 1/1 - Glioma 9 3.3 12 1/1 - Malignant Pinealoblastoma 15.5 2.05 20.75 1/2 1/2 Metastasis 7 44.3 16 - -
  23. 23. SECONDARY GK 12/18/2009 NSI-2009 Diagnosis Follow up period (months) Tumor volume (cm3) Radiation iso dose (Gy) Tumor control Worsening Beningn Meningiomas 54 12.5 12.52 4/4 - Gliomas 4 6.25 16 1/1 - Malignant Pinealoblastoma 9 1.4 24 1/1 - PNET 25 3.2 16 1/1 -
  24. 24. Pinealocytoma at GK Pinealocytoma post 24 months GK 12/18/2009 NSI-2009
  25. 25. Meningioma at GK Meningioma after 75 months GK 12/18/2009 NSI-2009
  26. 26. Pinealoblastoma Pre- Operative 12/18/2009 NSI-2009
  27. 27. At GK planning Pinealoblastoma 9 month after GK 12/18/2009 NSI-2009
  28. 28. <ul><li>Decrease in size - 7/14(50%) patients </li></ul><ul><li>Same size - 6/14 (42.8%) patients </li></ul><ul><li>Good tumor control - 13/14(92.8%) </li></ul><ul><li>(At an average follow up of 31.23.2 months) </li></ul>12/18/2009 NSI-2009
  29. 29. <ul><li>Primary GK in beningn disease </li></ul><ul><li>All patients had 100 % tumor control rates at 27 months </li></ul><ul><li>Primary GK in malignant tumors </li></ul><ul><ul><ul><li>Pinealoblastoma patients had good tumor control at 24months and 27 months post GK </li></ul></ul></ul><ul><ul><ul><li>Metastasis of a carcinoma breast died at 7 months follow up. </li></ul></ul></ul><ul><li>( Pinealoblastomas have mean survival rate of 29 months with surgery and adjuvant chemo/radiotherapy) </li></ul><ul><li>. </li></ul>12/18/2009 NSI-2009
  30. 30. <ul><li>Tatsuya Kobayashi et al studied out of 30 patients who were given radiosurgery after conventional treatment and concluded that pineocytomas, germinomas had 100% control rates, malignant germ cell tumors and pineoblastomas had 50% control rates </li></ul><ul><li>Stereotactic gamma radiosurgery for pineal and related tumors. Journal of neurooncology 2001; 54:301-309 . </li></ul>12/18/2009 NSI-2009
  31. 31. <ul><li>L Manera et al observed effective tumor control in germinomas, pinealoblastomas with recovery o f normal CSF pathways in 7 days of surgery. </li></ul><ul><li>Pineal region tumors: The role of stereotactic radiosurgery. Stereotactic and functional Neurosurg 1996;66(suppl 1):164-173 </li></ul>12/18/2009 NSI-2009
  32. 32. <ul><li>GK surgery valuable and safe alternative as a Primary treatment for posterior third ventricular tumors </li></ul><ul><li>Negligible morbidity in the medium term </li></ul><ul><li>Good local tumor control in even malignant tumors </li></ul>12/18/2009 NSI-2009

×